Cryosite Ltd (cte) Logo

Cryosite Ltd (CTE)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

CTE Chart

Snapshot

CTE's Principal Activity is the provision of temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport solutions and biological storage to the clinical trials, research and pharmaceutical industry, Provision of long term storage for cord blood and tissue samples.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) +31.66%
vs ASX 200 (1yr) +13.34%

Size

Market Capitalisation
ASX Rank 1,846 of 2,319
Sector Rank 174 of 199

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies AGN / MMJ / LSH
EPS $0.014
DPS $0.00
NTA per share $0.01

Broker Consensus

CTE is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Cryosite Limited (CTE) is into provision of supply chain logistics, management of pharmaceutical products used in clinical trials, management of biological materials and long-term storage of cord blood and tissue samples. Cryosite operates through Clinical Trials & Biological Storage and Logistics and Cord Blood and Tissues Storage.

Incorporation Details

Incorporated in NSW in December 1999.

Corporate Details

Head Office South Granville NSW 2142
Website www.cryosite.com
Registry Link Market Services
Auditor Mazars Risk & Assurance Pty Limited
Date Listed 9 May 2002

Upcoming Calendar (Forecasted)

Date Event
24/02/2022 Report (Interim)
24/08/2022 Report (Prelim)
24/08/2022 Report (Annual)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
14/03/2017 $0.005 0% $0.005 Interim 31/03/2017
07/09/2016 $0.005 0% $0.005 Final 04/10/2016
11/03/2016 $0.005 0% $0.005 Interim 31/03/2016
08/09/2015 $0.005 0% $0.005 Final 01/10/2015
13/03/2015 $0.005 0% $0.005 Interim 31/03/2015
08/09/2014 $0.01 0% $0.01 Final 24/09/2014
17/03/2014 $0.005 0% $0.005 Interim 04/04/2014
23/09/2013 $0.01 0% $0.01 Final 23/10/2013
18/03/2013 $0.005 0% $0.005 Interim 05/04/2013
28/09/2012 $0.005 0% $0.005 Final 23/10/2012
16/03/2012 $0.005 0% $0.005 Interim 05/04/2012

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio 0%
DRP No
DRP Features --

Directors & Management

Directors & Management

Name Title Since Bio
Mr John Hogg Chief Executive Officer Oct 2020
Mr Bryan Dulhunty Company Secretary,Non-Executive Director and Chairman Jun 2019 Director Bio icon

Mr Bryan Dulhunty

Company Secretary,Non-Executive Director and Chairman

Mr Dulhunty brings a wealth of life science experience to the position having been involved in the industry for the past 20 years. Mr Dulhunty provides a range of consulting services to the life science industry. Mr Dulhunty has served as a director of a number of listed ASX and non listed life science companies. He is a member of the Risk Committee.

Mrs Nicola Swift Non-Executive Director Nov 2016 Director Bio icon

Mrs Nicola Swift

Non-Executive Director

Mrs Swift has a background in the international investment management and securities industry as a research director, portfolio manager and equity analyst in London, Sydney and Boston with various global institutional investors. She is the chair of the Risk Committee.

Mr Andrew John Kroger Non-Executive Director Nov 2011 Director Bio icon

Mr Andrew John Kroger

Non-Executive Director

Mr Kroger has had a career in stockbroking, law and general management including two years running Forsayth Group in 1990 which was Australia's ninth largest gold producer at that time. Mr Kroger is the owner of Process Wastewater Technologies LLC, a company with its major business being in wastewater in the United States.

Jane Hao Chief Financial Officer N/A

Director Transactions

CTE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
06/09/21 Bryan Dulhunty Buy +1,300,000 $0.06 $78,000 Exercise of options
06/09/21 Bryan Dulhunty Exercise 1,300,000 $0.06 $78,000 Exercise of options
17/06/21 Andrew Kroger Buy +83,133 $0.43 $35,747 On-market trade
08/06/21 Andrew Kroger Buy +473,325 $0.36 $170,209 On-market trade
01/06/21 Andrew Kroger Buy +820,894 $0.36 $295,521 On-market trade
17/04/20 Andrew Kroger Buy +49,422 $0.08 $3,953 On-market trade
06/04/20 Andrew Kroger Buy +75,024 $0.074 $5,551 On-market trade
13/03/20 Andrew Kroger Buy +571,716 $0.07 $40,016 On-market trade
09/03/20 Andrew Kroger Buy +7,000 $0.07 $490 On-market trade
09/03/20 Andrew Kroger Buy +7,000 $0.07 $490 On-market trade
04/03/20 Andrew Kroger Buy +371,159 $0.067 $24,872 On-market trade
04/03/20 Andrew Kroger Transfer 713,590 $0.07 $49,951 Off-market transfer
04/03/20 Andrew Kroger Transfer 713,590 $0.07 $49,951 Off-market transfer
04/03/20 Andrew Kroger Buy +371,159 $0.067 $24,872 On-market trade
30/08/19 Andrew Kroger Buy +500,000 $0.057 $28,500 Off-market trade
04/07/19 Bryan Dulhunty Issued 1,300,000 $0.05 $65,000 Issue of options

Director Interests

The current holdings of CTE directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Bryan Dulhunty 06/09/2021 N/A 1,330,000 0 N/A
Andrew Kroger 30/06/2021 1,501,798 18,765,166 N/A N/A
Nicola Swift N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 16, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Mr Andrew Kroger And Related Entities 20,266,964 43.25%
BNP Paribas Nominees Pty Ltd 5,867,934 12.52%
Mr Gary Griffith Robins & Mr Allan James Robins 2,800,000 5.98%
DMX Capital Partners Limited 2,370,973 5.06%
Mr Alistair David Strong 2,000,000 4.27%
Bell Potter Nominees Ltd 1,758,236 3.75%
Mr Craig Anthony Rogers 1,067,126 2.28%
Mr Mark Gregory Kerr & Mrs Linda Marie Kerr 855,000 1.82%
Sunnyit Pty Ltd 559,518 1.19%
H F A Administration Pty Limited 480,000 1.02%
Mr Stephen Roberts 362,707 0.77%
Mrs Jane Susan Milliken 350,917 0.75%
Castlereagh Equity Pty Ltd 300,000 0.64%
Wifam Investments Pty Ltd 300,000 0.64%
Integument Pty Ltd 262,013 0.56%
Ms Marie Ludivine Sandrine Langevin & Mr Gary Griffith Robins 235,000 0.50%
M N J Holdings Pty Ltd 214,931 0.46%
Naron Nominees Pty Ltd 213,007 0.45%
Mrs Michele Eve Robins 200,000 0.43%
Ms Angeline Lim 200,000 0.43%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 42 241 64 105 37 489

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Robins Super Fund 16/08/2021 2,800,000 5.98
DMX Asset Management Limited 16/08/2021 2,370,973 5.06
Andrew John Kroger 06/09/2021 20,266,964 41.52

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
17-06-21 Andrew John Kroger 83,133 43.07 43.25
03-06-21 Andrew John Kroger 473,325 42.06 43.07
01-06-21 Andrew John Kroger 820,894 40.31 42.06
12-05-21 Robins Super Fund 2,800,000 -- 5.92
11-03-21 DMX Asset Management Limited 2,770,973 -- 5.91

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
09-03-21 Cell Care Australia Pty Ltd 546,193 15.9 14.8
05-03-21 Cell Care Australia Pty Ltd 712,607 17.4 15.9
23-02-21 Cell Care Australia Pty Ltd 522,393 18.6 17.4
16-02-21 Cell Care Australia Pty Ltd 534,995 19.7 18.6

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $0.13 30 June
2019 $0.05 28 June
2018 $0.09 29 June
2017 $0.16 28 June
2016 $0.21 28 June
2015 $0.35 30 June
2014 $0.36 30 June
Page Icon
CTE Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.